» Authors » Luciene Machado Dos Reis

Luciene Machado Dos Reis

Explore the profile of Luciene Machado Dos Reis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 28
Citations 355
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferreira A, Dos Reis L, Manteigas D, Carvalho A, Jorgetti V
Bone . 2024 Nov; 190:117309. PMID: 39490656
Despite its invasive character, bone biopsy followed by histomorphometry remains the gold standard for diagnosing and classifying many metabolic bone diseases. However, the interpretation of histomorphometric parameters requires comparison with...
2.
Ramos L, Via Reque Cortes D, Dos Reis L, Montenegro F, Arap S, Brescia M, et al.
J Bras Nefrol . 2023 Dec; 46(2):e20230024. PMID: 38039492
Introduction: Management of secondary hyperparathyroidism (SHPT) is a challenging endeavor with several factors contruibuting to treatment failure. Calcimimetic therapy has revolutionized the management of SHPT, leading to changes in indications...
3.
Carbonara C, Barreto J, Roza N, Quadros K, Dos Reis L, Carvalho A, et al.
J Bras Nefrol . 2023 Nov; 46(2):e20230119. PMID: 37947359
Introduction: Renal osteodystrophy (ROD) refers to a group of bone morphological patterns that derive from distinct pathophysiological mechanisms. Whether the ROD subtypes influence long-term outcomes is unknown. Our objective was...
4.
Zen R, Dominguez W, Braga I, Dos Reis L, Jorge L, Yu L, et al.
Diagnostics (Basel) . 2023 Jan; 13(2). PMID: 36673014
Introduction: Urinary CD80 has been shown to have good specificity for minimal change disease (MCD) in children. However, the investigation of circulating factors such as soluble urokinase plasminogen activator receptor...
5.
Duayer I, Duque E, Fujihara C, de Oliveira I, Dos Reis L, Machado F, et al.
Toxins (Basel) . 2021 Aug; 13(7). PMID: 34357974
Several factors contribute to renal-function decline in CKD patients, and the role of phosphate content in the diet is still a matter of debate. This study aims to analyze the...
6.
Siqueira F, Carneiro de Oliveira K, Dominguez W, Truyts C, Moyses R, Dos Reis L, et al.
Eur J Clin Nutr . 2021 Jan; 75(7):1126-1133. PMID: 33462459
Background/objective: Loss of renal function may induce secondary hyperparathyroidism (s-HPT), which triggers several complications leading to an extreme decline in quality of life and increased mortality in affected patients. We...
7.
Carbonara C, Dos Reis L, Quadros K, Roza N, Sano R, Carvalho A, et al.
J Bras Nefrol . 2020 Aug; 42(2):138-146. PMID: 32756862
Introduction: Mineral and bone disorders (MBD) are major complications of chronic kidney disease (CKD)-related adverse outcomes. The Brazilian Registry of Bone Biopsy (REBRABO) is an electronic database that includes renal...
8.
Nepomuceno Araujo M, Marques I, Graciolli F, Fukuhara L, Dos Reis L, Custodio M, et al.
Kidney Int . 2019 Sep; 96(5):1100-1104. PMID: 31526513
In an attempt to clarify the mechanisms of post-transplant bone disease we investigated the bone content and gene expression of several bone-related proteins. After a successful kidney transplant, the content...
9.
Marques I, Nepomuceno Araujo M, Graciolli F, Dos Reis L, Pereira R, Alvarenga J, et al.
J Am Soc Nephrol . 2019 Jan; 30(2):355-365. PMID: 30606784
Background: Bone and mineral disorders commonly affect kidney transplant (KTx) recipients and have been associated with a high risk of fracture. Bisphosphonates may prevent or treat bone loss in such...
10.
Barreto F, Costa C, Dos Reis L, Custodio M
J Bras Nefrol . 2018 Dec; 40(4):366-374. PMID: 30525179
Renal osteodystrophy (ROD), a group of metabolic bone diseases secondary to chronic kidney disease (CKD), still represents a great challenge to nephrologists. Its management is tailored by the type of...